Zhang Dan, Deng Ji-Jun, Xu Qin, Zeng Yang, Jiang Jun
Department of General Surgery (Thyroid Surgery), The Affiliated Hospital of Southwest Medical University, PR China.
Department of Thyroid and Breast Surgery, The Third People's Hospital of Yibin, PR China.
Heliyon. 2023 Jul 20;9(8):e18489. doi: 10.1016/j.heliyon.2023.e18489. eCollection 2023 Aug.
Glutathione peroxidase (GPx) is an important antioxidant enzyme in thyroid follicular cells. Reduced levels of expression in papillary thyroid cancer (PTC) are associated with poor prognosis. However, the reason for the decreased expression level of in PTC is unclear.
The expression of in papillary thyroid carcinoma and adjacent normal tissue (n = 18) was detected by Western blotting. Bioinformatics was used to predict the relationship between the level of GPx-3 and gender, age, lymph node metastasis, stage, BRAF mutation, and recurrence-free survival of patients. The possible upstream microRNAs of GPx-3 were analyzed by bioinformatics tools also. We verified the relationship between GPx-3 and upstream microRNA by dual luciferase reporter assay and enzyme-linked immunosorbent assay (ELISA).
The protein level of GPx-3 decreased in PTC, and analysis of public database datasets suggests that its decreased expression may be associated with the BRAF mutation. MiR-146b-5p was significantly overexpressed in PTC. The dual luciferase reporter assay verified the effect of miR-146b-5p on 3'-UTR of GPx-3 mRNA. Knockdown of miR-146b-5p in thyroid cancer cell lines TPC-1 and BCPAP increased expression levels, accompanied by an increase in the conversion of glutathione (GSH) to oxidized glutathione (GSSG).
In conclusion, the level of GPx-3 decreases in papillary thyroid carcinoma and impairs intracellular peroxide clearance, due to the inhibitory effect of miR-146b-5p. The accumulation of intracellular peroxides may contribute to the poor prognosis of thyroid cancer.
谷胱甘肽过氧化物酶(GPx)是甲状腺滤泡细胞中的一种重要抗氧化酶。甲状腺乳头状癌(PTC)中其表达水平降低与预后不良相关。然而,PTC中该表达水平降低的原因尚不清楚。
采用蛋白质免疫印迹法检测18例甲状腺乳头状癌及癌旁正常组织中GPx-3的表达。利用生物信息学预测GPx-3水平与患者性别、年龄、淋巴结转移、分期、BRAF突变及无复发生存率之间的关系。还通过生物信息学工具分析了GPx-3可能的上游微小RNA。我们通过双荧光素酶报告基因检测和酶联免疫吸附测定(ELISA)验证了GPx-3与上游微小RNA之间的关系。
PTC中GPx-3的蛋白水平降低,对公共数据库数据集的分析表明其表达降低可能与BRAF突变有关。miR-146b-5p在PTC中显著过表达。双荧光素酶报告基因检测验证了miR-146b-5p对GPx-3 mRNA 3'-UTR的作用。在甲状腺癌细胞系TPC-1和BCPAP中敲低miR-146b-5p可增加GPx-3表达水平,同时伴随着谷胱甘肽(GSH)向氧化型谷胱甘肽(GSSG)转化的增加。
总之,由于miR-146b-5p的抑制作用,甲状腺乳头状癌中GPx-3水平降低,损害细胞内过氧化物清除。细胞内过氧化物的积累可能导致甲状腺癌预后不良。